NCT02485418View on ClinicalTrials.gov

Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 24, 2023

Study Completion Date

January 24, 2023

Conditions
Migraine Headache
Interventions
DRUG

Propofol

Intravenous propofol infusion at 20 mcg/kg/min for 10 minutes, followed by an increase to 30 mcg/kg/min for 10 minutes and then by an increase to 40 mcg/kg/min for 40 minutes.

Trial Locations (1)

75235

Children's Health Children's Medical Center Dallas, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02485418 - Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients | Biotech Hunter | Biotech Hunter